These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26987311)

  • 1. Exploring the implications of distinct mutational signatures and mutation rates in aging and cancer.
    Fox EJ; Salk JJ; Loeb LA
    Genome Med; 2016 Mar; 8(1):30. PubMed ID: 26987311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clock-like mutational processes in human somatic cells.
    Alexandrov LB; Jones PH; Wedge DC; Sale JE; Campbell PJ; Nik-Zainal S; Stratton MR
    Nat Genet; 2015 Dec; 47(12):1402-7. PubMed ID: 26551669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signatures of mutational processes in human cancer.
    Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; ; ; ; ; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR
    Nature; 2013 Aug; 500(7463):415-21. PubMed ID: 23945592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutation in cancer and normal cells.
    Martincorena I; Campbell PJ
    Science; 2015 Sep; 349(6255):1483-9. PubMed ID: 26404825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding mutagenesis through delineation of mutational signatures in human cancer.
    Petljak M; Alexandrov LB
    Carcinogenesis; 2016 Jun; 37(6):531-40. PubMed ID: 27207657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection.
    Yadav VK; DeGregori J; De S
    Nucleic Acids Res; 2016 Mar; 44(5):2075-84. PubMed ID: 26883632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational signatures of redox stress in yeast single-strand DNA and of aging in human mitochondrial DNA share a common feature.
    Degtyareva NP; Saini N; Sterling JF; Placentra VC; Klimczak LJ; Gordenin DA; Doetsch PW
    PLoS Biol; 2019 May; 17(5):e3000263. PubMed ID: 31067233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related somatic mutations in the cancer genome.
    Milholland B; Auton A; Suh Y; Vijg J
    Oncotarget; 2015 Sep; 6(28):24627-35. PubMed ID: 26384365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SigsPack, a package for cancer mutational signatures.
    Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
    BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. decompTumor2Sig: identification of mutational signatures active in individual tumors.
    Krüger S; Piro RM
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):152. PubMed ID: 30999866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SomaMutDB: a database of somatic mutations in normal human tissues.
    Sun S; Wang Y; Maslov AY; Dong X; Vijg J
    Nucleic Acids Res; 2022 Jan; 50(D1):D1100-D1108. PubMed ID: 34634815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct mutation accumulation rates among tissues determine the variation in cancer risk.
    Hao D; Wang L; Di LJ
    Sci Rep; 2016 Jan; 6():19458. PubMed ID: 26785814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic Methods to Identify Mutational Signatures in Cancer.
    Islam SMA; Alexandrov LB
    Methods Mol Biol; 2021; 2185():447-473. PubMed ID: 33165866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs.
    Ng AS; Chan DKH
    Oncogene; 2023 Sep; 42(37):2713-2724. PubMed ID: 37573406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting genetic and environmental mutation signatures with model organisms.
    Segovia R; Tam AS; Stirling PC
    Trends Genet; 2015 Aug; 31(8):465-74. PubMed ID: 25940384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The shaping of cancer genomes with the regional impact of mutation processes.
    Lee SY; Wang H; Cho HJ; Xi R; Kim TM
    Exp Mol Med; 2022 Jul; 54(7):1049-1060. PubMed ID: 35902761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
    Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
    BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?
    DeGregori J
    Oncogene; 2013 Apr; 32(15):1869-75. PubMed ID: 22751134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Mosaicism and Cancer: Cause and Effect.
    Lichtenstein AV
    Cancer Res; 2018 Mar; 78(6):1375-1378. PubMed ID: 29472519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation Signatures Depend on Epigenomic Contexts.
    Coleman N; De S
    Trends Cancer; 2018 Oct; 4(10):659-661. PubMed ID: 30292349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.